Your browser doesn't support javascript.
loading
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.
Kitko, Carrie L; Arora, Mukta; DeFilipp, Zachariah; Zaid, Mohammad Abu; Di Stasi, Antonio; Radojcic, Vedran; Betts, Courtney B; Coussens, Lisa M; Meyers, Michael L; Qamoos, Hope; Ordentlich, Peter; Kumar, Vinit; Quaranto, Christine; Schmitt, Aaron; Gu, Yu; Blazar, Bruce R; Wang, Trent P; Salhotra, Amandeep; Pusic, Iskra; Jagasia, Madan; Lee, Stephanie J.
Afiliação
  • Kitko CL; Vanderbilt University Medical Center, Nashville, TN.
  • Arora M; University of Minnesota Masonic Cancer Center, Minneapolis, MN.
  • DeFilipp Z; Massachusetts General Hospital, Boston, MA.
  • Zaid MA; Indiana University Simon Cancer Center, Indianapolis, IN.
  • Di Stasi A; University of Alabama, Birmingham, AL.
  • Radojcic V; University of Utah Huntsman Cancer Institute, Salt Lake City, UT.
  • Betts CB; Syndax Pharmaceuticals, Inc, Waltham, MA.
  • Coussens LM; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Meyers ML; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Qamoos H; Syndax Pharmaceuticals, Inc, Waltham, MA.
  • Ordentlich P; Syndax Pharmaceuticals, Inc, Waltham, MA.
  • Kumar V; Kartos Therapeutics, Inc, Redwood City, CA.
  • Quaranto C; Syndax Pharmaceuticals, Inc, Waltham, MA.
  • Schmitt A; Syndax Pharmaceuticals, Inc, Waltham, MA.
  • Gu Y; Daiichi Sankyo, Inc, Basking Ridge, NJ.
  • Blazar BR; Syndax Pharmaceuticals, Inc, Waltham, MA.
  • Wang TP; Aerovate Therapeutics, Inc, Waltham, MA.
  • Salhotra A; Syndax Pharmaceuticals, Inc, Waltham, MA.
  • Pusic I; Syndax Pharmaceuticals, Inc, Waltham, MA.
  • Jagasia M; Division of Blood & Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN.
  • Lee SJ; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
J Clin Oncol ; 41(10): 1864-1875, 2023 04 01.
Article em En | MEDLINE | ID: mdl-36459673
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Síndrome de Bronquiolite Obliterante / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Síndrome de Bronquiolite Obliterante / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2023 Tipo de documento: Article